Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals

This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals.

Detalles Bibliográficos
Autores principales: Kanjee, Zahir, McCann, Marissa L., Freed, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122227/
https://www.ncbi.nlm.nih.gov/pubmed/33988710
http://dx.doi.org/10.1001/jamanetworkopen.2021.10079
_version_ 1783692543989383168
author Kanjee, Zahir
McCann, Marissa L.
Freed, Jason A.
author_facet Kanjee, Zahir
McCann, Marissa L.
Freed, Jason A.
author_sort Kanjee, Zahir
collection PubMed
description This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals.
format Online
Article
Text
id pubmed-8122227
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-81222272021-05-26 Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals Kanjee, Zahir McCann, Marissa L. Freed, Jason A. JAMA Netw Open Research Letter This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals. American Medical Association 2021-05-14 /pmc/articles/PMC8122227/ /pubmed/33988710 http://dx.doi.org/10.1001/jamanetworkopen.2021.10079 Text en Copyright 2021 Kanjee Z et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Kanjee, Zahir
McCann, Marissa L.
Freed, Jason A.
Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title_full Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title_fullStr Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title_full_unstemmed Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title_short Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
title_sort availability of specific direct oral anticoagulant reversal agents in us hospitals
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122227/
https://www.ncbi.nlm.nih.gov/pubmed/33988710
http://dx.doi.org/10.1001/jamanetworkopen.2021.10079
work_keys_str_mv AT kanjeezahir availabilityofspecificdirectoralanticoagulantreversalagentsinushospitals
AT mccannmarissal availabilityofspecificdirectoralanticoagulantreversalagentsinushospitals
AT freedjasona availabilityofspecificdirectoralanticoagulantreversalagentsinushospitals

Ejemplares similares